Creatine, Peptides & Bioregulators: Separating Hype From Truth w/ Dr William Seeds | Mind Pump 2667
Dr. William Seeds tells the Mind Pump hosts why he is skeptical of myostatin-blocker plus GLP-1 muscle claims and bioregulators, and what he says peptides can and cannot do.
With Dr. William Seeds (doctoral degree), Mind Pump hosts
Key moments
Tap a moment to play the video from there.
- 3:36Why few doctors use peptidesSeeds puts adoption among medical professionals at under 5% and says medical training does not cover the cell-level pathways peptides depend on.
- 10:19Exercise, mitochondria and moodSeeds explains his view of how energy production, glutamate recycling and muscle-derived signals connect exercise to anxiety and depression, and discusses ketones as a substrate.
- 26:45Creatine and methylationSeeds calls creatine misunderstood, describing it as an energy buffer and saying that supplementing it frees up methylation capacity the body would otherwise spend making creatine.
- 30:53Feedback loops and receptor desensitizationAsked whether peptides suppress the body's own production, Seeds says there is no negative feedback, though receptors can desensitize with certain peptides.
- 32:04Thymosin beta 4 versus TB500Seeds says the full thymosin beta 4 sequence acts on many pathways, while fragments such as TB500 may have a narrower, more anti-inflammatory effect.
- 34:47The BPC-157 and thymosin stackA host describes better definition after using the combination, and Seeds links the effect to senescence and inflammation modulation that he says affect muscle rebuilding.
- 37:43Myostatin and GLP-1 study critiqueThe hosts summarize a preclinical study combining semaglutide with myostatin and activin blockers. Seeds argues the extra muscle would be poor in function and carry long-term risks.
- 1:06:24GLP-1 evolution and retatrutideSeeds discusses the move from single to triple agonists and says he likes the glucagon element, expecting smaller doses to be enough.
- 1:11:20Bioregulators called hypeSeeds says oral bioregulators have not been replicated outside their originators, and he explains which few peptides can survive the gut.
- 1:16:09Why responses to peptides differSeeds says MOTS-c is a later-stage tool that works best on a healthy mitochondrial base, and he cautions against taking too many peptides at once.
What the video says
This Mind Pump episode is a long conversation between the hosts and Dr. William Seeds, who they introduce as a leading authority in peptide science. It opens with his view that peptides are one of the most disruptive medical developments in a long time. Seeds argues that peptides act on the root of a dysfunction through cell signaling, while drugs tend to address symptoms. He estimates that fewer than 5% of medical professionals have adopted this approach and says doctors are rarely taught the cell biology it requires.
The first half also covers general physiology. Prompted by a large study on exercise and depression, Seeds explains his view of how mitochondrial energy, glutamate handling and muscle-derived signals relate to anxiety and mood. He calls creatine a misunderstood supplement and discusses its link to methylation. On peptides specifically, he says there is no negative feedback loop of the testosterone kind, though receptor desensitization is possible with some. He says full-length thymosin beta 4 is not the same as the TB500 fragment, and he calls BPC-157 plus thymosin beta 4 one of his favorite combinations for athletic performance.
The longest segment is a critique of a preclinical study in which semaglutide was combined with a myostatin inhibitor and an activin A blocker. The hosts describe large fat loss with muscle gain. Seeds argues that this is not a miracle combination. In his view, the added muscle would be low in function, would reduce oxidative capacity, would use up satellite cells, could raise cancer and senescence risk, and would worsen glucose handling. He cites a double-muscled breed as an example of the pattern.
Later he discusses GLP-1 drugs, saying he likes the glucagon component of retatrutide and expects lower doses to be enough. He dismisses oral bioregulators as unreplicated marketing, says only a few peptides survive oral use, and explains why MOTS-c may work for some people and not others. He advises building a base first rather than stacking many peptides, and ends by warning about self-styled peptide courses. The episode includes sponsor reads. These are Seeds's opinions and are not presented here as established fact.
On each compound
BPC-15736:04
A host says he has used BPC-157 with thymosin beta 4 and noticed better definition. Seeds says the two have synergistic effects. Later he says BPC-157 is one of the few peptides that can be taken orally.
See how your DNA reads BPC-157TB-50033:31
Seeds says TB500 is a fragment of thymosin beta 4 and that fragments may be more anti-inflammatory without the immune-modulating range of the full peptide. He says the complete thymosin beta 4 is the effective one.
See how your DNA reads TB-500Semaglutide39:10
The hosts describe a preclinical study pairing semaglutide with myostatin and activin blockers. Seeds says the added muscle would be inefficient and that adding a GLP-1 does not offset those problems.
See how your DNA reads SemaglutideRetatrutide1:07:56
Seeds describes retatrutide as a triple agonist whose glucagon component he likes. He predicts lower doses will be enough. A host relays that bodybuilders report eating more carbohydrates and feeling better on it.
See how your DNA reads RetatrutideMOTS-c1:17:43
A host says MOTS-c made him feel energetic while others notice nothing. Seeds says he sees mitochondrial peptides as second or third stage tools that work best once oxidative phosphorylation is already in good shape.
See how your DNA reads MOTS-cEpithalon1:13:35
Seeds says the bioregulator work began with epitalon, which he says can be used orally only in large amounts, and that the oral approach did not hold up.
See how your DNA reads Epithalon“beware of an expert who tries to sell you something”
What this video doesn’t settle
- The preclinical myostatin study is described secondhand by the hosts, and Seeds says he does not recall the specific data.
- Seeds's claims about long-term effects of myostatin inhibition, such as satellite cell depletion and cancer risk, are his own mechanistic reasoning, and no human outcome data are presented.
- The bodybuilder reports on retatrutide and the hosts' personal stack results are anecdotes with no control group.
Questions this video answers
Do peptides shut down your body's own production like testosterone does?
Seeds says no, there is no negative feedback loop with peptides. He says the one thing that can happen is receptor desensitization or downregulation with certain peptides.
What does Dr. Seeds say about myostatin inhibitors combined with GLP-1 drugs?
He argues the combination is not a miracle. In his view the added muscle would be low in function, with reduced oxidative capacity, depleted satellite cells, higher senescence and cancer risk, and worse glucose handling. He says he cannot rule out that his concerns are incomplete but sees no way around them.
Is TB500 the same as thymosin beta 4?
According to Seeds, no. He says TB500 is a fragment, and fragments may be more anti-inflammatory without the broader immune-modulating effect of the full thymosin beta 4 sequence.
What does Seeds think of Khavinson bioregulators?
He calls them a marketing success rather than a working approach. He says oral peptides are mostly broken down by digestive enzymes, and that the supporting research comes only from the originators and has not been replicated elsewhere.
Why do some people respond to MOTS-c and others do not?
Seeds says it depends on cellular efficiency. He treats mitochondrial peptides as a later step after a base of oxidative phosphorylation and fat oxidation is in place, and he also points to overtraining as a reason for poor response.
Video by Mind Pump Show on YouTube, embedded as published. The summary is written by PeptidesDNA from the video; every claim in it is the speaker’s. Not affiliated with or endorsed by the creator. Not medical advice.
